Home / Markets / News / Divi's Laboratories slips 9% on subdued June quarter results

Divi's Laboratories slips 9% on subdued June quarter results

Operational revenue during the quarter grew 17 per cent YoY at Rs 1,163 crore against Rs 995 crore in the corresponding quarter of previous year

Premium

2 min read Last Updated : Aug 13 2019 | 10:10 AM IST

Shares of Divi's Laboratories slipped 9 per cent to Rs 1,512 on the BSE in Tuesday's early morning trade after the company reported 1 per cent year-on-year (YoY) growth in consolidated net profit at Rs 272 crore in the June quarter (Q1FY20), due to lower growth in revenue and higher raw material cost. The pharmaceutical company had a profit of Rs 268 crore during the same quarter last fiscal.

Operational revenue during the quarter grew 17 per cent YoY at Rs 1,163 crore against Rs 995 crore in the corresponding quarter of previous year.

EBITDA (earnings before interest,

Topics : Divis Laboratories Buzzing stocks

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in